The largest database of trusted experimental protocols

7 protocols using gst rankl

1

Osteoclastogenesis from Bone Marrow-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osteoclastogenesis in vitro was studied by plating bone marrow-derived macrophages (BMDMs) from 8-week-old mice in culture dishes containing α-MEM (GIBCO) with 10% FBS (MP Biomedicals). After incubation for 8 hr, nonadherent cells were collected, and cells were seeded (3×105 cells/dish) in 6 cm suspension dishes containing α-MEM with 10 ng/ml M-CSF (R&D Systems). After 2 days (about 80% confluent), adherent cells were used as osteoclast precursor cells after washing out the nonadherent cells. Cells were cultured in the presence of 10 ng/ml M-CSF and 235 ng/ml GST-RANKL (Oriental yeast, Japan) for 60 hr to generate osteoclast like cells.
+ Open protocol
+ Expand
2

Osteoclast Generation from Murine Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary murine calvarial cells were isolated from the calvariae of neonates, as previously described [14 (link)]. To generate osteoclasts, bone marrow cells were co-cultured for 6‒7 d with calvarial cells in minimal essential media (α-MEM) containing penicillin/streptomycin (100 units and 100 μg/ml, respectively), 2 mM L-glutamine, and 10% fetal bovine serum with or without baricitinib (Chemscene, Monmouth Junction, NJ) in the presence of 10−8 M 1,25D3 and 10−6 M PGE2 (both; Wako, Osaka, Japan).
Mice were sacrificed by cervical dislocation, and bone marrow cells were collected by flushing the tibia. Bone marrow macrophages were obtained from cultures treated with M-CSF (50 ng ml-1) for 3 d and subsequently cultured with or without baricitinib in the presence of M-CSF and GST-RANKL (200 ng ml-1; Oriental Yeast, Tokyo, Japan) for 3‒4 d. These cultures were fixed with 4% paraformaldehyde in PBS and stained for tartrate-resistant acid phosphatase (TRAP) activity, as previously described [14 (link)]. TRAP-positive multinuclear cells (TRAP+ MNC; more than three nuclei) were counted as osteoclasts.
+ Open protocol
+ Expand
3

Osteoclast Differentiation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW264.7 cells were seeded in NICO‐1 at a density of 7.5 × 103 cells per well or seeded in 96‐well plates at a density of 4.0 × 103 cells per well. Recombinant mouse sRANKL (GST‐RANKL; Oriental Yeast Co., Tokyo, Japan) was administered at a concentration of 50 ng·mL−1 along with seeding of RAW264.7 cells. On Day 5, the cells were stained with tartrate‐resistant acid phosphatase (TRAP) using a TRAP Staining Kit (Cosmo Bio, Tokyo, Japan). TRAP‐positive multinuclear cells containing three or more nuclei were counted as osteoclasts under a light microscope.
+ Open protocol
+ Expand
4

Osteoclast Differentiation Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Alpha-minimum essential medium (α-MEM) and fetal bovine serum (FBS) were purchased from Life Technologies (Carlsbad, CA, USA). Recombinant human M-CSF was purchased from R&D Systems (Minneapolis, MN, USA), and GST-RANKL was purchased from Oriental Yeast Co., Ltd (Shiga, Japan). Anti-trimethyl-histone H3 lysine 4 and anti-trimethyl-histone H3 lysine 27 were from Active Motif (rabbit polyclonal antibody, 39159, Carlsbad, CA, USA) and Millipore (rabbit polyclonal antibody, 07–449, Billerica, MA, USA), respectively. Anti-NFATc1 antibody detects all DNA binding domain-containing NFATc1 splicing isoforms, but not the closely related NFATc2 [27 (link)]. Anti-FAK, anti-Pyk2 and anti-Src antibodies were from Cell Signaling Technology (rabbit polyclonal antibody; Beverly, MA, USA).
+ Open protocol
+ Expand
5

In Vivo Imaging of Osteoclast Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Risedronate (50 µg/kg; EA Pharma Co., Ltd., Tokyo, Japan), alendronate (100 µg/kg; Wako Pure Chemical Industries), or minodronate (20 µg/kg; Chengdu‐D‐Innovation Pharmaceutical, Chengdu, China) dissolved in PBS was administered by i.v. injection to TRAP‐tdTomato or a3‐GFP mice, and images were acquired consecutively. In the experiments for TRAP‐tdTomato mice, mice were ovariectomized 1 month prior to imaging. In the experiments for a3‐GFP mice, GST‐RANKL (Oriental Yeast Co., Ltd.; 1 mg/kg in PBS) was injected intraperitoneally into mice every day beginning 2 days prior to imaging. No adverse events were observed.
+ Open protocol
+ Expand
6

Osteoclastogenesis Induction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human M-CSF was purchased from R&D Systems (Minneapolis, MN, USA), and TGF-β and SB431542 were from Sigma-Aldrich (St Louis, MO, USA). GST-RANKL was purchased from Oriental Yeast Co., Ltd (Shiga, Japan). Alpha-minimum essential medium (α-MEM) and fetal bovine serum (FBS) were purchased from Life Technologies (Carlsbad, CA, USA). Smad2/3 antibody was purchased from BD Biosciences (Monoclonal antibody, Mouse, 610843, San Jose, CA, USA), anti-trimethyl-histone H3 lysine 4 was from Activemotif (Polyclonal antibody, Rabbit, 39159, Carlsbad, CA, USA), anti-trimethyl-histone H3 lysine 27 was from Millipore (Polyclonal antibody, Rabbit, 07–449, Billerica, MA, USA), anti-β-actin was from Sigma-Aldrich (Polyclonal antibody, Rabbit, A2066, St Louis, MO, USA).
+ Open protocol
+ Expand
7

Regulation of Osteoclastogenesis by Hedgehog Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant M-CSF protein (Cat# 416-ML-500) was purchased from R&D Systems, Minneapolis, MN, USA; GST-RANKL (Cat# 47197900) from Oriental Yeast, Tokyo, Japan; cyclopamine (SMO inhibitor, Cat# 038-19311) from Wako, Osaka, Japan; GANT-58 (GLI1 inhibitor, Cat# CS-0507) from Chem Scene, Monmouth, NJ, USA; and GANT-61 (GLI1/2 inhibitor, Cat# AG-CR1-3561) from AdipoGen, Seoul, Korea.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!